Feb 21, 2026
TULSA, Okla. -Cardiac amyloidosis, once widely considered a fatal diagnosis, is now being detected earlier and treated with newly approved medications that doctors…
Feb 21, 2026
On 21 February, Lachlan Guyot and Henry Mayjor will be taking on the iconic Rottnest Channel Swim, swimming from Cottesloe to Rottnest Island as a duo team.This…
Feb 21, 2026
Driven by accelerating diagnosis of ATTR cardiomyopathy, sustained reliance on cost-effective chemotherapy, and rapid uptake of disease-modifying therapies in North…
Feb 20, 2026
Hear from a current student in the Clinical & Translational Research Certificate Program as they reflect on their experience in the program and the impact it…
Feb 20, 2026
The Transthyretin Amyloidosis – Quality of Life Questionnaire (ATTR-QOL) can effectively capture the multidimensional effect of ATTR, according to a new study…
Feb 20, 2026
Amyloid plaques accumulate years before dementia, driven by release of the Aβ peptide from amyloid precursor protein (APP) in neurons. Now, new evidence points to…
Feb 20, 2026
ORLANDO, Fla. - Cardiac amyloidosis is a systemic disorder that affects the heart and can also affect other organs such as the kidneys and nervous system.…
Feb 20, 2026
AbstractBackground and Objectives: Hereditary transthyretin amyloidosis (ATTRv) is a rare disease caused by pathogenic variants in the transthyretin (TTR) gene.…
Feb 20, 2026
Insulin-derived amyloidosis is a rare form of localised amyloidosis resulting from the aggregation of exogenous insulin into subcutaneous amyloid fibrils at…
Feb 20, 2026
AbstractAntibodies directed at the amyloid-β peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of…